Learn more

ANTICANCER INC

Overview
  • Total Patents
    330
  • GoodIP Patent Rank
    144,431
About

ANTICANCER INC has a total of 330 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are VETERINARMEDIZINISCHE UNI WIEN, DAVID GLADSTONE INST and MED COLLEGE GEORGIA RES INST.

Patent filings per year

Chart showing ANTICANCER INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tan Yuying 133
#2 Xu Mingxu 99
#3 Yang Meng 77
#4 Han Qinghong 45
#5 Li Lingna 42
#6 Jiang Ping 39
#7 Zhao Ming 27
#8 Li Shukuan 25
#9 Tang Li 25
#10 Yagi Shigeo 22

Latest patents

Publication Filing date Title
US2020029540A1 Transplantation method to increase the establishment rate of human tumors in immunodeficient mice
US2019153421A1 Orally Administered Composition to Lower Serum Methionine Levels and Method of Use
US2019011434A1 Methods to determine cancer treatment using robotic high-throughput drug sensitivity testing
US2018236011A1 Methods to enhance tumor-targeting by bacteria
CN104777107A Schiff-base conjugate of n, n-dibutyl-p-phenylenediamine with pyridoxal 5'-phosphate for improved homocysteine assays using pyridoxal 5'-phosphate-dependent enzymes
JP2015121543A Portable digital imaging system for fluorescence-guided surgery (FGS)
US2014193801A1 Schiff-base conjugate of N, N-dibutyl-P-phenylenediamine with pyridoxal 5′-phosphate for improved homocysteine assays using pyridoxal 5′-phosphate-dependent enzymes
US2014178341A1 Individualized bacterial treatment of pancreatic cancer
US2014180073A1 Portable digital imaging system for fluorescence-guided surgery
WO2013102118A2 Imageable patient tumors in mice
AU2008308697A1 Imageable rodent model of asthma
CN105075984A Rapid in vivo model for angiogenesis
CN101523205A Rapid in vivo model for angiogenesis
KR20090003149A Methods for identifying markers for early-stage human cancer, cancer progression and recurrence
CA2572756A1 Cancer selective auxotrophs
US2005238617A1 Methods for increasing protein polyethylene glycol (PEG) conjugation
CN1933784A Whole body imaging using portable observation systems
CA2554423A1 Whole body imaging using portable observation systems
WO2005070014A2 Enzymatic methionine assay
WO2005057488A2 Modular system for multi-color, whole body fluorescence imaging